LT2805723T - Kladribino režimas, skirtas išsėtinei sklerozei gydyti - Google Patents

Kladribino režimas, skirtas išsėtinei sklerozei gydyti

Info

Publication number
LT2805723T
LT2805723T LTEP14001970.4T LT14001970T LT2805723T LT 2805723 T LT2805723 T LT 2805723T LT 14001970 T LT14001970 T LT 14001970T LT 2805723 T LT2805723 T LT 2805723T
Authority
LT
Lithuania
Prior art keywords
multiple sclerosis
treating multiple
cladribine
regimen
cladribine regimen
Prior art date
Application number
LTEP14001970.4T
Other languages
English (en)
Lithuanian (lt)
Inventor
Giampiero De Luca
Arnaud Ythier
Alain Munafo
Maria Lopez-Bresnahan
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34930135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2805723(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of LT2805723T publication Critical patent/LT2805723T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
LTEP14001970.4T 2004-12-22 2005-12-20 Kladribino režimas, skirtas išsėtinei sklerozei gydyti LT2805723T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63866904P 2004-12-22 2004-12-22
EP04106909 2004-12-22

Publications (1)

Publication Number Publication Date
LT2805723T true LT2805723T (lt) 2018-02-12

Family

ID=34930135

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14001970.4T LT2805723T (lt) 2004-12-22 2005-12-20 Kladribino režimas, skirtas išsėtinei sklerozei gydyti

Country Status (11)

Country Link
AT (1) ATE547106T1 (de)
CY (1) CY1125491T1 (de)
DK (1) DK1827461T3 (de)
ES (4) ES2495392T3 (de)
HU (1) HUE035859T2 (de)
LT (1) LT2805723T (de)
ME (1) ME01333B (de)
PT (4) PT3332789T (de)
RS (1) RS52219B (de)
SI (1) SI1827461T1 (de)
UA (1) UA96260C2 (de)

Also Published As

Publication number Publication date
CY1125491T1 (el) 2025-05-09
PT3332789T (pt) 2022-07-05
UA96260C2 (ru) 2011-10-25
ES2495392T3 (es) 2014-09-17
ES2428741T3 (es) 2013-11-11
PT4070800T (pt) 2024-12-30
ATE547106T1 (de) 2012-03-15
RS52219B (sr) 2012-10-31
ME01333B (me) 2013-12-20
ES2382554T3 (es) 2012-06-11
SI1827461T1 (sl) 2012-05-31
HUE035859T2 (en) 2018-05-28
PT2805723T (pt) 2018-01-25
DK1827461T3 (da) 2012-03-26
ES2666146T3 (es) 2018-05-03
PT1827461E (pt) 2012-05-07

Similar Documents

Publication Publication Date Title
NO20073813L (no) Kladribinregime for behandling av multippel sklerose
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
TW200508214A (en) Novel compounds
TW200619220A (en) New hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5, 6, 7, 8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-mithoxy-n-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TW200640908A (en) Chemical compounds
TW200621730A (en) Chemical compounds
TW200806300A (en) New therapeutic combinations for the treatment of depression
TW200630093A (en) Dose forms
TW200616974A (en) Chemical compounds
WO2007135172A3 (en) Cladribine regimen for treating multiple sclerosis
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
MY191349A (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
TW200621259A (en) Chemical compounds
MEP55308A (en) New pharmaceutical compositions containing flibanserin polymorph a
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
MY146802A (en) Novel drugs for treating respiratory diseases
UA96260C2 (ru) Режим применения кладрибина для лечения рассеянного склероза
MX2009005125A (es) Pirrolo[1,2-a]imidazoldiona efectiva en el tratamiento de neurotoxicidad periferica inducida por agentes quimioterapeuticos.
UA91694C2 (ru) Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций
TW200634002A (en) Chemical compounds
BRPI0618370A2 (pt) formulação aerossol de medicamento, uso do mesmo e kit de inalação
TW200720239A (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
TW200626149A (en) Tricycles, their manufacture and use as pharmaceutical agents